Holocene Advisors, LP Insmed Inc Transaction History

Holocene Advisors, LP

$22.9 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $4.53 Million - $6.15 Million	-193,626 Reduced 10.71%	1,614,862 $50 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $5.45 Million - $7.39 Million	-274,390 Reduced 13.17%	1,808,488 $45.7 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $2.17 Million - $2.79 Million	-132,269 Reduced 5.97%	2,082,878 $43.9 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $1.24 Million - $1.66 Million	76,280 Added 3.57%	2,215,147 $37.8 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $6.93 Million - $9.45 Million	408,359 Added 23.6%	2,138,867 $42.7 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $24.3 Million - $32.8 Million	-1,163,314 Reduced 40.2%	1,730,508 $37.3 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $2.56 Million - $3.86 Million	150,243 Added 5.48%	2,893,822 $57.1 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $12.4 Million - $17.1 Million	606,993 Added 28.41%	2,743,579 $64.5 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $1.31 Million - $1.7 Million	-50,689 Reduced 2.32%	2,136,586 $58.2 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $7.05 Million - $9.25 Million	-314,004 Reduced 12.55%	2,187,275 $60.2 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $17.5 Million - $26.1 Million	723,666 Added 40.71%	2,501,279 $71.2 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $27.4 Million - $37.6 Million	849,522 Added 91.53%	1,777,613 $60.5 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $6.61 Million - $8.52 Million	-210,131 Reduced 18.46%	928,091 $30.9 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $816,114 - $1.08 Million	31,389 Added 2.84%	1,138,222 $36.6 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $3.47 Million - $7.23 Million	245,920 Added 28.57%	1,106,833 $30.5 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $11.7 Million - $29.3 Million	860,913 New	860,913 $13.8 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.27 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$1.05 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$929 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$775 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$482 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account